IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q1 2023 Holdings

Filed 2023-05-15 | 3 holdings | $4.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Werewolf Therapeutics Inc(HOWL)COM95075A107$1.5M589,10235.7%
Vaccitech PLC(BRNS)ADS91864C107$1.4M642,20433.5%
Tscan Therapeutics Inc(TCRX)COM89854M101$1.3M630,00030.8%